LAB.FARMACEUTICOS ROVI

15/11 CET
Closure
ISIN ES0157261019
Last:
24.7000
Dif:
0.1000
(0.41 %)
Volume:
16,009
1 Year Statistical Data
Data
Listed Days 255
IBEX Correlation (%) 0.76
Volatility [Y] 31.17
Alpha Ratio 0.14
Beta Ratio 0.17
Standard Deviation 1.63
Variance 2.66
Consolidated
2019-2 2018-4 Var.
Net Sales (MM€) 177.536 303.203 -41.45
P.B.T (MM€) 17.464 16.680 4.68
Net Profit (MM€) 16.161 17.895 -9.67
Equity (MM€) 299.310 287.475 4.12
Reserves (MM€) 0.673 0.600 11.67
Amortization (MM€) -8.715 -12.044 -27.65
Net Profit/Sales (%) 9.103 5.902 54.22
Sales per share (€) N.A. N.A. N,A,
C.Increase
Thursday
01
/Nov
2018
Type of capital increase: Con Prima
Percentage of the new securities that are issued: 99
Percentage of the old securities:
Price per share: 14.5
Unit nominal of the capital increase:
Rights trading: N
Nominal amount of the capital increase: 33,103
Unit price to be paid in the capital increase: 15
IPO date: 01/11/2018
Capital increase starting date: 01/11/2018
capital increase ending date: 01/11/2018
Economic rights: //
Capital increase in the year: 1
Tuesday
09
/Oct
2018
Type of capital increase: Con Prima
Percentage of the new securities that are issued: 11
Percentage of the old securities: 100
Price per share: 14.5
Unit nominal of the capital increase:
Rights trading: N
Nominal amount of the capital increase: 331,034
Unit price to be paid in the capital increase: 15
IPO date: 09/10/2018
Capital increase starting date: 09/10/2018
capital increase ending date: 09/10/2018
Economic rights: //
Capital increase in the year: 1